Firm & fund profile / Sourced portfolio
Wilson Sonsini Goodrich & Rosati
Tracked participation in 2 Atlas companies, with 0 explicitly attributed leads.
2portfolio companies
2round participations
0lead positions
Nov 2025latest activity
Capital activity
Portfolio
CompanyLatest valuationFirst → latestRoundsRoleLatest round
IT
Iambic Therapeutics—Nov 2025 → Nov 20251 roundParticipantOversubscribed financing (round size disclosed as “over $100 million”)